Aspire Real Estate Investors, Inc. focuses on investing, developing, remodeling and managing a portfolio of multi-family properties in metropolitan areas of the United States. The company is headquartered in Irvine, California.
| Revenue (TTM) | $26.93M |
| Gross Profit (TTM) | $4.74M |
| EBITDA | $-69.91M |
| Operating Margin | -595.00% |
| Return on Equity | -103.30% |
| Return on Assets | -13.70% |
| Revenue/Share (TTM) | $0.28 |
| Book Value | $2.29 |
| Price-to-Book | 1.76 |
| Price-to-Sales (TTM) | 17.65 |
| EV/Revenue | 67.98 |
| EV/EBITDA | -12.17 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 279.30% |
| Shares Outstanding | $125.90M |
| Float | $109.00M |
| % Insiders | 11.08% |
| % Institutions | 48.55% |
Volatility is currently expanding
DALLAS, July 28, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that it will hold a Capital Markets Day in London on Tuesday, September 8, 2026, beginning at 10:00 a.m. ET (3:00 p.m. BST).
ASP Isotopes Inc. (ASPI) Discusses Noble Africa's Merger Plans and Strategy to Become a Publicly Traded Helium Platform Transcript
DALLAS, July 21, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) (“ASPI”) today announced that Quantum Leap Energy LLC (“we,” "QLE" or the "Company"), a wholly-owned subsidiary of ASPI dedicated to advancing innovative technologies and processes across critical segments of the fission and fusion nuclear fuel cycle, has signed a research agreement with the Texas A&M Engineering Experiment Station (TEES) to advance and de-risk the commercial production of high-purity uranium hexafluoride (UF6), a critical feedstock in the existing nuclear fuel enrichment supply chain. This agreement reflects the growing momentum across Texas' nuclear industry and highlights the value of collaboration in strengthening the domestic nuclear fuel supply chain.
Noble Africa was created to unlock the value of Renergen's Virginia Gas Project through a public company focused on helium and LNG Learn why the Virginia Gas Project is positioned to become one of the world's most strategic helium developments as global supply tightens and demand accelerates DALLAS, TX AND ANN ARBOR, MI / ACCESS Newswire / July 17, 2026 / ASP Isotopes Inc. (NASDAQ:ASPI) ("ASP Isotopes" or "ASPI"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, and ENDRA Life Sciences Inc. (NASDAQ:NDRA) ("ENDRA" or "NDRA"), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), today announced that RedChip Companies will host an investor webinar featuring Noble Africa, a wholly owned subsidiary of ASP Isotopes and the holding company for Renergen Limited, on Tuesday, July 21, 2026, at 4:15 p.m. ET. The webinar will highlight Noble Africa's proposed merger (the "Proposed Merger" and, together with the related transactions, the "Proposed Transactions") with ENDRA, which, if completed, is expected to result in Noble Africa becoming a Nasdaq-listed public company trading under the ticker symbol "NOBA.
Combination, if successful, would establish Noble Africa as a Nasdaq-listed, helium platform for Renergen's Virginia Gas Project
ASP Isotopes has previously announced that it has signed three commercial contracts for the supply of enriched Silicon-28 to U.S.-based customers, and expects to make initial commercial shipments of enriched Silicon-28 in Q3 2026. The first 18 stages (comprising segments one and two) of the Silicon-28 enrichment facility have now successfully operated for over three weeks at target enrichment levels.
MOU establishes framework for collaboration with the goal to supply HALEU to European advanced reactor developer, beginning 2028 MOU establishes framework for collaboration with the goal to supply HALEU to European advanced reactor developer, beginning 2028
Technology Commercialization Leader Expected to Enhance QLE's Government Partnerships and Advanced Materials Strategy Technology Commercialization Leader Expected to Enhance QLE's Government Partnerships and Advanced Materials Strategy
First Commercial Shipments Expected Across Multiple Isotopes in 2026 Expect to Obtain Helium Phase 1 Nameplate Capacity in Q3 2026 EBITDA Target of Greater Than $300 Million in 2031 Cash, Cash Equivalents and Short-Term Marketable Securities of $333 million as of December 31, 2025 Business Update Conference Call Scheduled for 8:00 AM ET on April 13, 2026 DALLAS, April 13, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today provided a business update highlighting operational progress across its nuclear medicine, electronics, and nuclear energy platforms. “2026 is the year we expect to showcase our technology at scale.
DALLAS, April 10, 2026 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ: ASPI) ("ASP Isotopes" or the "Company"), an advanced materials company focused on developing technologies and processes for the production of critical materials used in multiple industries, today announced that Paul Mann, Executive Chairman and Chief Executive Officer at ASP Isotopes, will host a business update conference call and webcast on Monday, April 13, 2026, at 8:00 AM ET.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ASPI and any ticker you trade — then tracks every position and per-strategy win rate.
